Free Trial

Rein Therapeutics (RNTX) Earnings Date, Estimates & Call Transcripts

Rein Therapeutics logo
$1.83 -0.03 (-1.61%)
As of 04:00 PM Eastern

Rein Therapeutics Earnings Summary

Actual EPS
(Apr. 7)
-$0.26 Missed By -$0.26

Rein Therapeutics released Q4 2024 earnings on April 7, 2025, reporting an EPS of -$0.26. With a trailing EPS of -$3.47, Rein Therapeutics' earnings are expected to grow next year, from ($1.56) to ($1.41) per share.

Q4 2024 Earnings Resources

Get Rein Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rein Therapeutics and other key companies, straight to your inbox.

Sign Up

Rein Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.21-$0.21-$0.21
Q2 20251-$0.24-$0.24-$0.24
Q3 20251-$0.28-$0.28-$0.28
Q4 20251-$0.22-$0.22-$0.22
FY 20254($0.95)($0.95)($0.95)

Rein Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/7/2025Q4 2024--$0.26 -$0.26-$1.89--

Rein Therapeutics Earnings - Frequently Asked Questions

Rein Therapeutics (NASDAQ:RNTX) last announced its quarterly earning data on Monday, April 7, 2025. Learn more on RNTX's earnings history.

Rein Therapeutics (NASDAQ:RNTX) has a recorded net income of -$15.73 million. RNTX has generated -$3.47 earnings per share over the last four quarters.

Rein Therapeutics's earnings are expected to grow from ($1.56) per share to ($1.41) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:RNTX) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners